Markus Schwarz

21.2k total citations · 3 hit papers
230 papers, 12.3k citations indexed

About

Markus Schwarz is a scholar working on Biological Psychiatry, Psychiatry and Mental health and Behavioral Neuroscience. According to data from OpenAlex, Markus Schwarz has authored 230 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Biological Psychiatry, 69 papers in Psychiatry and Mental health and 58 papers in Behavioral Neuroscience. Recurrent topics in Markus Schwarz's work include Tryptophan and brain disorders (101 papers), Stress Responses and Cortisol (58 papers) and Bipolar Disorder and Treatment (34 papers). Markus Schwarz is often cited by papers focused on Tryptophan and brain disorders (101 papers), Stress Responses and Cortisol (58 papers) and Bipolar Disorder and Treatment (34 papers). Markus Schwarz collaborates with scholars based in Germany, United States and Austria. Markus Schwarz's co-authors include Norbert Müller, Michael Riedel, Aye-Mu Myint, Manfred Ackenheil, Elif Weidinger, Sandra Dehning, Rudolf Gruber, Ilja Spellmann, Urs Meyer and Bianka Leitner and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Gastroenterology.

In The Last Decade

Markus Schwarz

224 papers receiving 12.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

2006 628 citations Norbert Müller, Markus Schwarz et al. Molecular Psychiatry profile →
The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression

2007 524 citations Norbert Müller, Markus Schwarz Molecular Psychiatry profile →
Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases

2017 443 citations Natalie Moll, Markus Schwarz et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Markus Schwarz	5.8k	3.4k	3.1k	2.7k	1.5k	230	12.3k
Günter Kenis	3.4k 0.6×	2.1k 0.6×	3.0k 1.0×	2.1k 0.8×	944 0.6×	147	10.9k
Marta Kubera	4.9k 0.8×	1.8k 0.5×	3.6k 1.2×	1.9k 0.7×	1.3k 0.8×	179	9.5k
Brian J. Miller	5.7k 1.0×	3.3k 1.0×	2.8k 0.9×	1.5k 0.6×	1.2k 0.8×	162	10.4k
Undine E. Lang	3.5k 0.6×	2.2k 0.7×	2.6k 0.8×	2.9k 1.1×	1.6k 1.1×	377	17.4k
Olivia Dean	4.3k 0.7×	3.4k 1.0×	1.5k 0.5×	1.9k 0.7×	783 0.5×	184	11.1k
László Vécsei	4.7k 0.8×	4.3k 1.3×	2.6k 0.8×	3.4k 1.3×	1.9k 1.3×	617	16.0k
Jason C. O’Connor	6.7k 1.2×	1.4k 0.4×	5.1k 1.6×	1.8k 0.7×	2.9k 1.9×	80	11.8k
Hiroshi Kunugi	3.0k 0.5×	2.9k 0.9×	2.0k 0.6×	4.2k 1.6×	912 0.6×	446	15.7k
Simon Scharpé	3.4k 0.6×	1.6k 0.5×	2.6k 0.8×	2.3k 0.9×	645 0.4×	190	11.7k
Eugène Bosmans	4.6k 0.8×	1.9k 0.6×	3.7k 1.2×	1.2k 0.5×	922 0.6×	104	10.1k

Countries citing papers authored by Markus Schwarz

Since Specialization

Citations

This map shows the geographic impact of Markus Schwarz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Schwarz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Schwarz more than expected).

Fields of papers citing papers by Markus Schwarz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Schwarz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Schwarz. The network helps show where Markus Schwarz may publish in the future.

Co-authorship network of co-authors of Markus Schwarz

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Schwarz. A scholar is included among the top collaborators of Markus Schwarz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Schwarz. Markus Schwarz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paal, Michael, et al.. (2025). Optimizing therapeutic drug monitoring of mirtazapine — applying therapeutic reference range, concentration–dose ratio/dose-related concentration, and metabolic ratio in a naturalistic setting. European Journal of Clinical Pharmacology. 81(11). 1677–1687.

Moll, Natalie, Elif Weidinger, Bianka Burger, et al.. (2021). Mycoplasma pneumoniae IgG positivity is associated with tic severity in chronic tic disorders. Brain Behavior and Immunity. 99. 281–288. 4 indexed citations

Addabbo, Francesco, Valentina Baglioni, Anette Schrag, et al.. (2020). Anti‐dopamine D2 receptor antibodies in chronic tic disorders. Developmental Medicine & Child Neurology. 62(10). 1205–1212. 15 indexed citations

Arteaga-Henríquez, Gara, Bianka Burger, Elif Weidinger, et al.. (2020). Activation and deactivation steps in the tryptophan breakdown pathway in major depressive disorder: A link to the monocyte inflammatory state of patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 107. 110226–110226. 20 indexed citations

Müller, Norbert, Daniela Krause, Aye-Mu Myint, et al.. (2019). Childhood Adversity and Current Stress are related to Pro- and Anti-inflammatory Cytokines in Major Depression. Journal of Affective Disorders. 253. 270–276. 51 indexed citations

Krause, Daniela, Sabine Riemer, Francisco Pedrosa Gil, et al.. (2018). Stability of Cellular Immune Parameters over 12 Weeks in Patients with Major Depression or Somatoform Disorder and in Healthy Controls. NeuroImmunoModulation. 25(1). 7–17. 3 indexed citations

Kranaster, Laura, Carolin Hoyer, Suna Su Aksay, et al.. (2018). Biomarkers for Antidepressant Efficacy of Electroconvulsive Therapy: An Exploratory Cerebrospinal Fluid Study. Neuropsychobiology. 77(1). 13–22. 23 indexed citations

Kranaster, Laura, Carolin Hoyer, Suna Su Aksay, et al.. (2017). Antidepressant efficacy of electroconvulsive therapy is associated with a reduction of the innate cellular immune activity in the cerebrospinal fluid in patients with depression. The World Journal of Biological Psychiatry. 19(5). 379–389. 35 indexed citations

Euteneuer, Frank, Markus Schwarz, Ralf Schmidmaier, et al.. (2014). Blunted exercise-induced mobilization of monocytes in somatization syndromes and major depression. Journal of Affective Disorders. 166. 156–164. 8 indexed citations

10.

Myint, Aye-Mu, Brigitta Bondy, Thomas C. Baghai, et al.. (2013). Tryptophan metabolism and immunogenetics in major depression: A role for interferon-γ gene. Brain Behavior and Immunity. 31. 128–133. 57 indexed citations

11.

Euteneuer, Frank, et al.. (2012). Increased soluble interleukin-2 receptor levels are related to somatic but not to cognitive-affective features in major depression. Brain Behavior and Immunity. 26(8). 1244–1248. 21 indexed citations

12.

Müller, Norbert, Aye-Mu Myint, & Markus Schwarz. (2012). Inflammation in Schizophrenia. Advances in protein chemistry and structural biology. 88. 49–68. 69 indexed citations

13.

Musil, Richard, Markus Schwarz, Michael Riedel, et al.. (2011). Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression — No influence of celecoxib treatment. Journal of Affective Disorders. 134(1-3). 217–225. 102 indexed citations

14.

Euteneuer, Frank, et al.. (2011). Psychobiological aspects of somatization syndromes: Contributions of inflammatory cytokines and neopterin. Psychiatry Research. 195(1-2). 60–65. 19 indexed citations

15.

Euteneuer, Frank, et al.. (2010). Depression, cytokines and experimental pain: Evidence for sex-related association patterns. Journal of Affective Disorders. 131(1-3). 143–149. 45 indexed citations

16.

Müller, Norbert & Markus Schwarz. (2008). A psychoneuroimmunological perspective to Emil Kraepelins dichotomy. European Archives of Psychiatry and Clinical Neuroscience. 258(S2). 97–106. 95 indexed citations

17.

Schulze, Thomas G., Sevilla D. Detera‐Wadleigh, Nirmala Akula, et al.. (2008). Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder. Molecular Psychiatry. 14(5). 487–491. 123 indexed citations

18.

Seemüller, Florian, Heinz Grunze, Markus Schwarz, et al.. (2008). The Impact of Homocysteine Levels on Cognition in Euthymic Bipolar Patients. The Journal of Clinical Psychiatry. 69(6). 899–906. 39 indexed citations

19.

Neumeister, Alexander, Xian‐Zhang Hu, David A. Luckenbaugh, et al.. (2006). Differential Effects of 5-HTTLPR Genotypes on the Behavioral and Neural Responses to Tryptophan Depletion in Patients With Major Depression and Controls. Archives of General Psychiatry. 63(9). 978–978. 114 indexed citations

20.

Bondy, Brigitta, Thomas C. Baghai, Christo Minov, et al.. (2003). Substance P serum levels are increased in major depression: preliminary results. Biological Psychiatry. 53(6). 538–542. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact